Integra Lifesciences Holdings (IART) Profit After Tax (2009 - 2026)

Integra Lifesciences Holdings has disclosed Profit After Tax across 18 years of filings, most recently posting -$4.8 million for Q2 2026.

• In Q2 2026, Profit After Tax rose 99.03% year-over-year to -$4.8 million; the TTM figure through Jun 2026 stood at -$13.2 million (up 97.39% YoY), while the FY2025 annual figure was -$516.5 million, down 7337.7% from the prior year.
• Profit After Tax came in at -$4.8 million for Q2 2026 at Integra Lifesciences Holdings, down from -$4.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $55.7 million in Q3 2022 to a low of -$490.9 million in Q2 2025.
• Average Profit After Tax over 5 years is -$17.6 million, with a median of $3.4 million recorded in 2023.
• Year-over-year, Profit After Tax sank 3858.02% in 2025 and jumped 99.03% in 2026.
• Over 5 years, Profit After Tax stood at $15.2 million in 2022, then jumped by 30.23% to $19.8 million in 2023, then surged by 47.13% to $29.2 million in 2024, then tumbled by 90.75% to $2.7 million in 2025, then tumbled by 276.85% to -$4.8 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$4.8 million in Q2 2026, -$4.6 million in Q1 2026, and $2.7 million in Q4 2025.